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http://dx.doi.org/10.1016/j.bgm.201
2214-0247/Copyright ª 2014, TaiwanAbstract This study was undertaken to assess the frequency of angiotensin converting
enzyme (ACE) insertion/deletion (I/D) polymorphism in patients with type 2 diabetes mellitus.
A total of 162 patients with type 2 diabetes and 160 individuals without this disease were
analyzed. From the diabetes group, 81 patients with cardiovascular risk (according to Amer-
ican Diabetes Association parameters) were selected to form another subgroup. For polymor-
phism identification, two polymerase chain reactions were performed: one reaction to identify
all genotypes and a second one to confirm the presence of the I allele. The observed genotype
frequencies were as follows: diabetes group I/I (19.1%), I/D (52.5%), D/D (28.4%); control group
I/I (12.5%), I/D (55.6%), D/D (31.9%); and diabetes with cardiovascular risk group I/I (16.0%), I/
D (59.3%), D/D (24.7%). No statistically significant difference was observed between the allelic
and genotypic frequencies in the analyzed groups. Previous studies reported an association be-
tween the D allele and type 2 diabetes in Caucasian and East Asian populations. However, in
mixed populations, such as those found in Brazil, such an association was not found. This fact
does not discard the need for more studies on the frequencies of this polymorphism in the Bra-
zilian population and the associations with risk factors, which can compromise the quality of
life of diabetes patients.
Copyright ª 2014, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
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100 A.C. Bonini Domingos et al.IntroductionDiabetes mellitus is a glucose homeostasis disturbance that
affects 5% of the world population, and is characterized by
absolute or relative insulin deficiency and/or resistance to
this hormone. Type 2 diabetes mellitus (T2DM), considered
the most frequent form of diabetes, is characterized by
modifications in the insulin action and secretion, being
generally associated with genetic susceptibility.1 It is often
associated with complications that include risk for devel-
oping atherosclerosis, cardiovascular diseases, nephropa-
thy, retinopathy, and neuropathy, which makes this
condition a serious public health problem.1,2
Angiotensin converting enzyme (ACE) catalyzes the
conversion of angiotensin I to angiotensin II, which sustains
and modulates blood pressure, volemic control, and regu-
lation of kidney and systemic circulation, thereby influ-
encing glomerular filtration, such as sodium tubular
reabsorption. It also performs intracellular functions,
including cellular hyperplasia and/or hypertrophy, with
proinflammatory and pro-oxidant action, which results in
cellular toxicity and apoptosis. Modifications in the
renineangiotensinealdosterone system bring consequences
to cells from endothelial and muscular tissues including
inflammatory process, thrombotic events, and cardiovas-
cular complications. Some reports demonstrated that a low
degree of chronic inflammatory process predicts a risk of
glucose intolerance and diabetes type 2.3e11
There are reports about several polymorphisms related
to ACE, and one of these is the insertion/deletion (I/D) of
the 287-bp fragment in the 16th intron of the ACE gene at
the locus 17q23.3.12 The enzyme encoded by the D allele
presents higher activity than that encoded by the I
allele.12,13 Some studies associate the presence of the D
allele and D/D genotype to predisposition to coronary ar-
tery disease, and myocardial infarction in diabetic and
nondiabetic individuals.14,15
Considering the number of variables influencing the
beginning, development, and prognosis of diabetes, it is
therefore necessary to understand the relationship be-
tween the environmental and genetic factors related to this
disease. Therefore, the aim of the present study was to
evaluate the frequency of the ACE I/D polymorphism in
diabetic and nondiabetic patients in the Brazilian popula-
tion group.Materials and methods
Participants
In this study, 162 peripheral blood samples from diabetic
patients and 160 samples from individuals without this dis-
ease were analyzed. The diabetic patients group, nominated
as the test group, was composed of participants aged be-
tween 37 and 89 years, representing both sexes and admix-
ture ethnicity.16 The diagnosis of diabetes was based on
fastingbloodsugar (referencevalue70e99.00mg/dL),HbA1c
(4.8e6.0%), and evaluation of clinical history. The comple-
mentary tests were total cholesterol (<200 mg/dL), high-
density lipoprotein cholesterol level (HDLc; >40 mg/dL),low-density lipoprotein cholesterol (LDLc; <130 mg/dL,
Friedewald formula), and triglycerides (<150 mg/dL).
The American Diabetes Association17 reported that dia-
betic patients with HDLc under 40 mg/dL, or LDLc above
100 mg/dL, or triglycerides above 150 mg/dL have higher
risks of developing a heart disease.
Based on these standard data, 81 patients from the test
group who had one or more cardiovascular disease risk
factors cited previously were selected to form another
study group named “With risk of cardiovascular disease”.
The control group was composed of healthy individuals
aged between 40 and 85 years, representing both sexes and
admixture ethnicity, who are voluntary blood donors.
DNA extraction and polymerase chain reaction of
samples
After informed consent was obtained, 5 mL of peripheral
blood sample was collected in tubes containing EDTA
and stored at 8C for up to 1 week. Genomic DNA extraction
was performed using the modified phenolechloroform
method.18 Polymerase chain reaction (PCR)19 was per-
formed in a volume of 25 mL that contained 1.5mM MgCl2,
10 buffer without MgCl2, 0.12mM dNTP, 0.8 U Taq Poly-
merase (Biotools, Madrid, Spain), 100 ng genomic DNA, and
0.2mM of each primer: 50-CTG GAG ACC ACT CCC ATC CTT
TCT-30 (sense) 50-GAT GTG GCC ATC ACA TTG GTC AGA T-30
(antisense). The cycling process was performed as follows:
denaturation in 95C for 5 minutes, followed by 35 cycles of
95C for 30 seconds, 58C for 30 seconds, and 72C for 1
minute, and by the end an extension of 72C for 5 minutes.
In this first reaction, the primers that flank the polymorphic
region allows the identification of a 490-bp fragment that
corresponds to the insertion (I) and another fragment of
190-bp that corresponds to the deletion (D).
The possibility of 10% erroneous results has been
described owing to a preferential amplification of the D
allele in heterozygous genotypes. In order to correct this
problem, a new PCR with specific primers for the I allele
amplification was performed in all samples classified as D/D
genotype. The primers used in this new reaction were 50-
TGG GAC CAC AGC GCC CGC CAC TAC-30 (sense) and 50-TCG
CCA GCC CTC CCA TGC CCA TAA-30 (antisense).20 This sec-
ond reaction was performed under the same conditions as
the first one, except for the annealing temperature of 64C.
The presence of the I allele was assessed by the presence of
a 335-bp fragment, and the absence of amplification indi-
cated the presence of the D allele.
Statistical analysis
For the statistical analysis, the Chi-square test and Fisher’s
exact test were performed with an alpha of 5% for the
polymorphism frequency using Statistica software, StatSoft
Inc, Tulsa, OK, USA (version 7.0). As no available evidence
favored any genetic models of inheritance for the poly-
morphism under study, the genotype frequencies were
evaluated among each other, as follows: DD versus ID versus
II and also DD versus ID þ II (additive model), DD þ ID versus
II (dominant model) and DD versus ID þ II (recessive model),
in order to observe any possible codominant, additive,
ACE polymorphism and T2DM 101dominant, and recessive effects of the D allele, respec-
tively. HardyeWeinberg and odds ratio (OR) analysis with a
confidence interval (CI) of 95% was also performed.
Results
The genotypes distribution related to the ACE I/D poly-
morphism were in HardyeWeinberg equilibrium. As for the
obtained genotypes in this study, higher frequencies of
heterozygous (I/D) were observed, followed by homozygous
for the D allele (D/D) and I allele (I/I) in all study groups.
Tables 1 and 2 show the genotype frequencies for test,
control, and cardiovascular risk groups and also the OR
value, for each group in comparison with the control group.
Higher frequencies of the D allele were observed in all
the studied groups. The frequencies of the D allele were
similar between males and females in the patient group.
However, the male control group presented a higher fre-
quency of the D allele. In the cardiovascular risk group, this
pattern remained the same. Tables 3 and 4 present the
allelic frequency of the polymorphism analyzed and the OR
value for each group in comparison with the control group.
However, no statistically significant differences were found
between the allelic and genotypic frequencies in the
analyzed groups.
The comparison of genotypic frequencies between pa-
tients and controls under the dominant model (D/D þ I/D
vs. I/I) revealed p Z 0.07, and the analysis for the same
groups under the additive model (D/D vs. I/I) showed
p Z 0.08. The OR was 2.45, with 95% CI of 1.01e5.91
(pZ 0.07; data not shown in tables). The risk of developing
diabetes or cardiovascular diseases was calculated for men
and women, and for the group test, the risk for developing
cardiovascular diseases was also calculated in the control
and diabetic patients. However, no significant values were
observed in any of the groups and models of inheritance
analyzed.
Discussion
Our results corroborate the results of Costa et al,21 who
evaluated the frequency of ACE I/D polymorphism in Bra-
zilian patients with T2DM and did not find a relationship
between this polymorphism and the disease. Stephens
et al22 found an association between type 2 diabetes and
the polymorphism in question in a Caucasian population.Table 1 Genotypic frequencies of ACE polymorphisms and com
Patients
N (%)
Male Female Total Male
I/I 14 (21.21) 17 (17.70) 31 (19.14) 10 (9.90)
I/D 32 (48.48) 53 (55.20) 85 (52.50) 53 (52.50)
D/D 20 (30.31) 26 (27.10) 46 (28.40) 38 (37.60)
Total 66 (100) 96 (100) 162 (100) 101 (100)
p < 0.05 indicates significant difference, Fisher’s exact test.
ACEZ angiotensin converting enzyme; CIZ confidence interval; D/D
insertion; OR Z odds ratio; T2DM Z type 2 diabetes mellitus.These data are corroborated by the methanalysis made by
Zhou et al,23 who reported an association between the D
allele and diabetes in Caucasians and East Asian pop-
ulations, but not in Turkish and mixed populations, such as
those found in Brazil.
In respect to the patients within the cardiovascular
disease risk group, a statistically significant difference was
observed between the allelic and genotypic frequencies of
ACE polymorphism when compared to patients and control
groups. Some studies have revealed an association of the D
allele with cardiovascular disease in Turkish, French, and
Chinese populations.24e26 Zintzaras et al27 reported an as-
sociation of the same allele with coronary artery disease in
Caucasian and Turkish populations when the additive sta-
tistical model was used (D/D vs. I/I). In East Asian in-
dividuals, some associations were observed when a
recessive statistical model was performed (D/D vs. D/I þ I/
I), whereas in black, Latin, and East Indian populations no
significant associations were observed.
Stephens et al,22 studying a Caucasian population, re-
ported that no difference(s) existed between allelic and
genotypic frequencies in diabetic patients with and without
cardiovascular diseases. Our data are coincident to those
reported by other authors, because the study population is
mixed, with contributions from several ethnic groups, such
as Caucasian, African descendants, and other native
groups.16
The genotypic and allelic frequencies observed in our
study are similar to those cited by Costa et al,21 who
evaluated the association between the ACE I/D poly-
morphism and metabolic syndrome in patients with dia-
betes type 2 from south Brazil, and to the study performed
by Sakuma et al,28 who evaluated the same polymorphisms
in Brazilian African descendants with coronary artery dis-
ease from Mato Grosso do Sul State, Brazil. In both studies,
the higher frequencies of the I/D genotype, followed by D/
D and I/I, were observed.
When comparing our frequencies in a Brazilian mixed
population with those of other nations, such as Spanish,
other European populations in general, and Lebanese as
well as Afro-Americans, who are part of a population
ancestry study,16 we observed similar results. However, our
results differed from those of other studies performed in a
Brazilian population such as the study conducted by Freitas
et al,29 who reported 78.21% (I/I), 16.0% (I/D), and 5.13%
(D/D) in individuals from the northeast Amazon region, and
Alves-Correˆa et al,30 who evaluated this polymorphism inparison of OR between T2DM patients and control groups.
Control
N (%)
OR 95% CI p
Female Total
10 (16.90) 20 (12.50) 1.656 0.900e3.050 0.105
36 (61.01) 89 (55.62) 0.881 0.568e1.365 0.570
13 (22.00) 51 (31.88) 0.848 0.526e1.365 0.496
59 (100) 160 (100)
Z deletion/deletion; I/DZ insertion/deletion; I/IZ insertion/
Table 2 Genotypic frequencies of ACE polymorphisms and comparison of OR between cardiovascular disease risk and control
groups.
Cardiovascular disease risk
N (%)
Control
N (%)
OR 95% CI p
Male Female Total Male Female Total
I/I 6 (18.75) 7 (14.30) 13 (16.00) 10 (9.90) 10 (16.95) 20 (12.5) 1.338 0.628e2.850 0.450
I/D 18 (56.25) 30 (61.22) 48 (59.30) 53 (52.50) 36 (61.02) 89 (55.6) 1.160 0.675e1.995 0.591
D/D 8 (25.00) 12 (24.48) 20 (24.70) 38 (37.60) 13 (22.03) 51 (31.9) 0.701 0.383e1.283 0.249
Total 32 (100) 49 (100) 81 (100) 101 (100) 59 (36.87) 160 (100)
p < 0.05 indicates significant difference, Fisher’s exact test.
ACEZ angiotensin converting enzyme; CIZ confidence interval; D/DZ deletion/deletion; I/DZ insertion/deletion; I/IZ insertion/
insertion; OR Z odds ratio.
Table 3 Allelic frequencies of ACE gene and comparison of OR between T2DM patients and control groups.
Patients
N (%)
Control
N (%)
OR 95% CI p
Male Female Total Male Female Total
Allele I 60 (45.45) 87 (45.31) 147 (45.40) 73 (36,10) 56 (47.50) 129 (40.30) 1.230 0.900e1.681 0.195
Allele D 72 (54.55) 105 (54.69) 177 (54.60) 129 (63.90) 62 (52.50) 191 (59.70)
Total 132 (100) 192 (100) 324 (100) 202 (100) 118 (100) 320 (100)
p < 0.05 indicates significant difference, Fisher’s exact test.
ACEZ angiotensin converting enzyme; CIZ confidence interval; DZ deletion; IZ insertion; ORZ odds ratio; T2DMZ type 2 diabetes
mellitus.
102 A.C. Bonini Domingos et al.women with and without breast cancer from Sa˜o Paulo
State, and observed rates of 46.0% (D/D), 37.0% (I/D), and
17.0% (I/I). We believe that these differences are attrib-
utable to genetic differences inherent to the ancestry
populations from south, southeast, and north Brazilian
regions.16
The HardyeWeinberg analysis indicates that the ob-
tained data are concise and demonstrate the reality of the
studied population. Some studies reported variations in the
allelic and genotypic frequencies in several ethnic groups,
and we believe that this fact, which is related to the high
admixture of the Brazilian population, and the presence of
haplotypes in ACE I/D polymorphism31 are factors that
contribute to the observed differences between our study
and other studies performed in different populations.
Niu et al32 revealed that the ACE D allele is significantly
associated with an increased risk for T2DM and appears to
be inherited additively. This effect can be enhanced ifTable 4 Allelic frequencies of ACE gene and comparison of OR
Cardiovascular disease risk
N (%)
Male Female Total Male
Allele I 30 (46.90) 44 (47.80) 74 (47.40) 73 (36.10)
Allele D 34 (53.10) 48 (52.20) 82 (52.60) 129 (63.80)
Total 64 (100) 92 (100) 156 (100) 202 (100)
p < 0.05 indicates significant difference, Fisher’s exact test.
ACEZ angiotensin converting enzyme; CIZ confidence interval; DZ
mellitus.combined with risk factors such as sedentariness, being
overweight, alcoholism, and tobacco use. Therefore, for a
correct classification of development risk and complica-
tions related to T2DM, we believe that it is necessary to
analyze genetic polymorphisms, haplotypes, and other
genes that might be related to ACE gene function, post-
transcriptional and translational interactions, and even
ambient factors such as sedentariness, age, and food
habits.Conclusion
Despite the lack of association between the analyzed
polymorphism, T2DM, and risk of cardiovascular complica-
tions, it is important to emphasize that the presence of the
D allele should be considered in order to avoid complica-
tions to the diabetic patient. For a correct classification ofbetween cardiovascular disease risk and control groups.
Control
N (%)
OR 95% CI p
Female Total
56 (47.5) 129 (40.30) 1.336 0.909e1.965 0.141
62 (52.5) 191 (59.70)
118 (100) 320 (100)
deletion; IZ insertion; ORZ odds ratio; T2DMZ type 2 diabetes
ACE polymorphism and T2DM 103the genetic factors that interfere in the beginning and
complications of this disease in the Brazilian population, we
believe it is necessary to conduct larger studies on this
polymorphism and its haplotypes, just like the relationship
between these factors and the environmental risks influ-
encing the diabetic patient’s quality of life. Moreover, the
knowledge generated by research conducted on new forms
of treatment and prevention, is one of the main objectives
of the World Health Organization33 and the American Dia-
betes Association for control of this disease, which is
considered a worldwide epidemic in this decade.34Conflicts of interest
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